HOG Study - GI03-53 - "Phase II trial of neoadjuvant capecitabine plus irinotecan followed by combined modality capecitabine and radiation therapy for patients with locally advanced rectal cancer: a Hoosier Oncology Group study" was presented as a poster presentation at the ASCO GI in January. Congratulations to Dr. Chiorean and her research team.
Read Abstract